Objective
Recombinant DNA (rDNA) technologies (genetic, protein and metabolic engineering) allow the production of a wide range of peptides, proteins and bio-chemicals from naturally non producing cells. Pharmaceutical products and industrial enzymes were the first biotech-products on the world market made by means of rDNA. Another interesting class of heterologous expressed genes are those conferring new metabolic abilities to the host cells. Host cell physiology plays a key role in the production of recombinant proteins. Growth and nutrient utilisation, as well as key properties of the product, depend on the physiological characteristics of the host. Many of these features follow similar patterns in all important host organisms (mainly bacteria, yeasts, filamentous fungi, plant and animal cells): e.g. protein synthesis, folding and secretion, stress responses, by-product formation or genetic instability.
According to the format of the first Conference ("Recombinant protein production with prokaryotic and eukaryotic cells. A comparative view on host physiology", Semmaring Austria, 2000), that treated the above issues in all major groups of host organisms, a Second International Conference on this subject will be organized at the Villa Erba Center in Cemobbio (Como), Italy, November 14th-16th, 2002.
Also for this second Conference the main goal is to provide the framework in which to identify the major bottlenecks in the pipeline from gene to product from different hosts and to discuss future strategies to overcome these bottlenecks. Moreover, the Conference aims at further strengthening and enlarging the scientific and industrial network established at the first meeting. The Conference will be structured in special lectures, sessions with both invited lectures and contributed presentations, poster sessions and a scientific-technical exhibition.
A special session entitled: "Recombinant Protein Production in China" is also planned.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology bacteriology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- natural sciences biological sciences genetics DNA
- natural sciences biological sciences microbiology mycology
- natural sciences biological sciences biochemistry biomolecules proteins enzymes
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.